GlaxoSmithKline's Consumer Healthcare unit said today it reached an agreement with Laclede, a privately held company, to buy the Biotene brand, a treatment for dry mouth, for $170 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results